Aktis Oncology Inc (AKTS)

Finanzdaten der Aktis Oncology Inc-Aktie (AKTS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2024-09-30	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	4.87%3.38	3.23	9.03	5.86	7.51
	24.49%32.28	25.93	9.64	50.07	22.96
Research and Development	26.17%25.28	20.04	2.69	7.26	5.97
Operating Income/Loss	27.27%-28.90	-22.71	-5.34	-50.70	-22.61
Nonoperating Income/Loss	8.54%4.76	4.38	-1.08	-58.10	-0.70
	31.75%-24.14	-18.33	-6.42	-108.80	-23.31
Attributable To Parent	31.75%-24.14	-18.33	-6.42	-108.80	-23.31
Available To Common Stockholders, Basic	31.75%-24.14	-18.33	-6.42	-108.80	-23.31
Basic Average Shares	13.72%55.30	48.63	154.43	10.24	91.28
Diluted Average Shares	13.72%55.30	48.63	154.43	10.24	91.28
Basic Earnings Per Share	15.79%-0.44	-0.38	-0.04	-1.14	-0.26
Diluted Earnings Per Share	15.79%-0.44	-0.38	-0.04	-1.14	-0.26